ANEBULO PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-171.1K | — |
| FY2021 | — | $21.4M | — |
| FY2022 | — | $15.1M | — |
| FY2023 | — | $10.6M | $11.2M |
| FY2024 | — | $3.8M | $3.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-171.1K | — |
| FY2021 | — | $21.4M | — |
| FY2022 | — | $15.1M | — |
| FY2023 | — | $10.6M | $11.2M |
| FY2024 | — | $3.8M | $3.1M |